Table of Contents:

Part I:  Cardiovascular Complications and In Vitro Models

Chapter 1.     Heart Disease in AIDS

Chapter 2.     Mechanisms of Atherogenesis in HIV Infection

Chapter 3.     Role of HIV-1 Macropionocytosis and Cardiomyocyte Apoptosis in the Pathogenesis of HIV Cardiomyopathy

Chapter 4.     HIV-1 and the Blood-Brain Barrier

Chapter 5.     HIV, Cocaine, and the Heart:  Pathophysiology and Clinical Implications

Chapter 6.     HIV-Associated Thrombotic Microangiopathy

Chapter 7.     Pathogenesis of HIV-Associated Vasculopathy

Chapter 8.     Causative Factors of Cardiovascular Complications in AIDS

Chapter 9.     HIV-Associated Vascular Disease and Endothelial Injury

Chapter 10.   Tat-Induced Angiogenesis

Part II:  Nutrition:  Causation and Prevention

Chapter 11.   Nutritents as Modulators of Immune Dysfunction and Dyslipidemia in AIDS

Chapter 12.   Antioxidant Vitamins and Heart Disease Prevention

Chapter 13.   Nutrients and Treatment of Heart Disease in AIDS

Chapter 14.   Will Soy Protein Help HIV Patients with Cardiovascular Risk?

Chapter 15.   N-3 Fatty Acid Supplementation in AIDS Patients with Cardiac Complications

Chapter 16.   A Role for Dietary Protein in the AIDS Wasting Syndrome and Heart Disease?

Chapter 17.   Role of Antioxidants in Reducing Heart Disease in HIV-Infected Patients

Chapter 18.   Antioxidant Vitamins and Antiretroviral Therapy During HIV Infection:  Effects on Oxidative Damage

Chapter 19.   Vitamin E Retards Heart Disease in AIDS Patients

Part III:  Drug Abuse:  Promotion of Retroviral Heart Disease

Chapter 20.   HIV- and Cocaine-Induced Subclinical Atherosclerosis

Chapter 21.   Cocaine, HIV, and Heart Disease:  Research at NIDA and Recommendations for Future Research

Chapter 22.   Cocaine-Induced Exacerbation of Viral Myocarditis

Chapter 23.   Role of the Catecholamine-Nitric Oxide System in Cocaine- and HIV-Induced Vascular Inflammation and Its Pharmacological Implications

Chapter 24.   Cardiovascular Complications of HIV/AIDS and Substance Abuse

Part IV:  Lipodystrophy

Chapter 25.   Lipids, Lipodystrophy, and AIDS

Chapter 26.   Pathogenesis of HIV-Associated Cardiovascular Complications in HAART Era

Chapter 27.   Lipodystrophy Syndrome and HIV Disease

Chapter 28.   The Role of N-3 Fatty Acids in Preventing Coronary Artery Disease and Arrhythmias in AIDS Patients:  A Hypothesis

Part V: Animal Models of Retrovirus-Related Heart Disease

Chapter 29.   Cardiovascular Involvement in Simian AIDS in Nonhuman Primates

Chapter 30.   Cardiac Disease in HIV-1 Tg Animals

Chapter 31.   Murine AIDS and HIV-1 Dementia